44 results
S-3
EX-4.13
OCUP
Ocuphire Pharma Inc
Shelf registration
10 Jan 24
5:00pm
S-3
EX-4.17
OCUP
Ocuphire Pharma Inc
Shelf registration
10 Jan 24
5:00pm
S-3
EX-4.15
OCUP
Ocuphire Pharma Inc
Shelf registration
10 Jan 24
5:00pm
S-3
EX-4.16
OCUP
Ocuphire Pharma Inc
Shelf registration
10 Jan 24
5:00pm
8-K/A
EX-4.1
OCUP
Ocuphire Pharma Inc
7 Jun 21
Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:05pm
8-K
EX-4.1
qm4 3iqyvzcms3kg
4 Jun 21
Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:48pm
8-K
EX-4.1
fvq5nxauspvgraa
4 Feb 21
Entry into a Material Definitive Agreement
12:00am
S-4
EX-4.9
52e umfop7
6 Jul 20
Registration of securities issued in business combination transactions
4:08pm
8-K
EX-4.1
corxfk7ei7u qef
1 Jul 20
Entry into a Material Definitive Agreement
8:37am
425
EX-4.1
ae0dmjl5t
1 Jul 20
Business combination disclosure
8:35am
8-K
EX-4.2
1l427cs
19 Jun 20
Rexahn and Ocuphire Enter into Definitive Merger Agreement
9:02am
8-K
EX-4.1
oa5hoyh26zhlx9
19 Jun 20
Rexahn and Ocuphire Enter into Definitive Merger Agreement
9:02am
425
EX-4.1
uwgmqv6jr 2hnoy
19 Jun 20
Business combination disclosure
9:00am
425
EX-4.2
pm8768yr7u 90i
19 Jun 20
Business combination disclosure
9:00am